James M. Frates
2018
Compensation breakdown
Non-Equity Incentive Plan | $309,000 |
---|---|
Option Awards | $1,849,438 |
Salary | $536,732 |
Stock Awards | $908,010 |
Other | $13,750 |
Total | $3,616,930 |
Frates received $1.8M in option awards, accounting for 51% of the total pay in 2018.
Frates also received $309K in non-equity incentive plan, $536.7K in salary, $908K in stock awards and $13.8K in other compensation.
Rankings
In 2018, James M. Frates' compensation ranked 3,135th out of 14,244 executives tracked by ExecPay. In other words, Frates earned more than 78.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,135 out of 14,244 | 78th |
Division Manufacturing | 1,164 out of 5,765 | 80th |
Major group Chemicals And Allied Products | 406 out of 2,128 | 81st |
Industry group Drugs | 335 out of 1,817 | 82nd |
Industry Pharmaceutical Preparations | 258 out of 1,391 | 82nd |
Pay ratio
James M. Frates' Pay | $3,616,930 |
---|---|
Median Employee's Pay | $146,775 |
Pay Ratio | 25to 1 |
In 2018, the annual total compensation of James M. Frates was $3,616,930.
The annual total compensation of the median employee at Alkermes was $146,775.
The ratio of James M. Frates' pay to the pay of median employee was therefore 25 to one.
Frates' colleagues
We found six more compensation records of executives who worked with James M. Frates at Alkermes in 2018.
2018
Richard Pops
Alkermes
Chief Executive Officer
2018
James Robinson
Alkermes
Chief Operating Officer
2018
Mark Stejbach
Alkermes
Former Senior Vice President and Chief Commercial Officer
2018
Kathryn Biberstein
Alkermes
Chief Administrative Officer
2018
Craig Hopkinson
Alkermes
Chief Medical Officer
2018
David Gaffin
Alkermes